Sayre Therapeutics manufactures and markets medicines, drug-delivery devices, companion diagnostics, and diagnostic imaging agents to medical, surgical, radiation and interventional radiologists, and rheumatologists. The Company is focused on niche products and orphan medications in areas with unmet needs and sub-optimal treatment options that include small molecules, recombinant proteins, and monoclonal antibodies in oncology and immunology.